An assessment if the current scientific environment in the United Kingdom is contributing to development and adoption of stratified medicines
MSc (Med) in Pharmaceutical Affairs Department of Pharmacy and Pharmacology University of Witwatersrand 11 January 2016 === Introduction: In October 2010 the Stratified Medicines Innovation Platform (SMIP) was created under the oversight of the Technology Strategy Board (TSB) to help accelerate...
Main Author: | Engelbrecht, Van Zyl |
---|---|
Format: | Others |
Language: | en |
Published: |
2016
|
Online Access: | http://hdl.handle.net/10539/21308 |
Similar Items
-
Assessing the economic case for stratified medicine
by: Goren, Amir, S.M. Massachusetts Institute of Technology
Published: (2008) -
Comparison of age-stratified seroprevalence of antibodies against norovirus GII in India and the United Kingdom.
by: Vipin Kumar Menon, et al.
Published: (2013-01-01) -
The practice of Asian medicine in the United Kingdom
by: Aslam, M.
Published: (1979) -
A Study of Current Regulation and Issues on Cosmetic Medicine -Lessons from United Kingdom, United States and France
by: Yeh, Chan Kun, et al.
Published: (2016) -
Development of sustainable georesources for the built environment in the United Kingdom
by: McMillan, Andrew A., et al.
Published: (2008-06-01)